Opsoclonus-ataxia caused by childhood neuroblastoma: Developmental and neurologic sequelae

Pediatrics

Volumn 109, Issue 1, 2002, Pages 86-98

  Mitchell, Wendy G ^a,e   Davalos Gonzalez, Yolanda ^b   Brumm, Virdette L ^c   Aller, Sonia K ^d   Burger, Elvira ^e   Turkel, Susan B ^f   Borchert, Mark S ^a   Hollar, Susan ^g   Padilla, Sonia ^h,i  

^a Department of Neurology Division ^*  (United States)

^b University Affiliated Program   (United States)

^c Division of Biokinesiology and Physical Therapy   (United States)

^d Trauma Psychiatry Program   (United States)

^e CHILDREN S HOSPITAL LOS ANGELES   (United States)

^f Epidemiology and Human Genetics   (United States)

^g Psychiatry   (United States)

^h UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

ⁱ CALIFORNIA STATE UNIVERSITY   (United States)

Author keywords

Ataxia; Developmental sequelae; Neuroblastoma; Opsoclonus; Paraneoplastic disorders

Indexed keywords

CORTICOSTEROID; CORTICOTROPIN; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; ATAXIA; BEHAVIOR DISORDER; CANCER SURGERY; CHILD; CHILD BEHAVIOR; CHILD DEVELOPMENT; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DISEASE COURSE; FEMALE; HORMONAL THERAPY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTELLIGENCE; LANGUAGE DISABILITY; LONG TERM CARE; MALE; MOTOR DEVELOPMENT; NEUROBLASTOMA; OCCULT CANCER; OPSOCLONUS; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; QUESTIONNAIRE; SPEECH DISORDER; STEROID THERAPY;

ABDOMINAL NEOPLASMS; ADOLESCENT; ATAXIA; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT; MALE; NEUROBLASTOMA; PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM; THORACIC NEOPLASMS;

EID: 0036141016     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Neurologic paraneoplastic syndromes
2. The pathophysiology of paraneoplastic neurological syndromes
3. Paraneoplastic syndromes affecting the central nervous system
4. Paraneoplastic neurologic syndromes: Pathogenesis and physiopathology
5. Paraneoplastic syndromes of the nervous system
6. Myoclonic encephalopathy of infants or "dancing eyes syndrome." Report of 7 cases with long-term follow-up and review of the literature (cases with and without neuroblastoma)
7. The coincidence of neuroblastoma and acute cerebellar encephalopathy
8. Opsoclonus and neuroblastoma
9. Cerebellar ataxia and opsoclonus as the initial manifestations of myoclonic encephalopathy associated with neuroblastoma
10. Infantile polymyoclonia-opsoclonus syndrome and neural crest tumors
11. Opsoclonus as the initial manifestation of occult neuroblastoma
12. The neurobiology of the opsoclonus-myoclonus syndrome
13. Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: Clinical outcome and antineuronal antibodies - A report from the Children's Cancer Group Study
14. Long-term outcome in children with opsoclonus-myoclonus and ataxia and coincident neuroblastoma
15. Long-term neurologic outcome in children with opsoclonus-myoclonus associated with neuroblastoma: A report from the Pediatric Oncology Group
16. Favorable prognosis for survival in children with coincident opso-myoclonus and neuroblastoma
17. Clinical outcome in children with acute cerebellar encephalopathy and neuroblastoma
18. Opsoclonus/myoclonus: Paraneoplastic syndrome of neuroblastoma
19. Opsoclonus/ataxia in childhood neural crest tumors: A chronic neurologic syndrome
20. Poor outcome in patients with advanced stage neuroblastoma and coincident opsomyoclonus syndrome
21. The cytoplasmic Purkinje onconeural antigen cdr2 down-regulates c-Myc function: Implications for neuronal and tumor cell survival
22. Anti-Yo positive paraneoplastic cerebellar degeneration associated with ovarian carcinoma: Case report and review of the literature
23. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome
24. Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration
25. Serum autoantibodies in childhood opsoclonus-myoclonus syndrome: An analysis of antigenic targets in neural tissues
26. Serum IgM autoantibodies in patients with paraneoplastic and idiopathic opsoclonus myoclonus syndrome (OMS) recognize neurofilament and histone in neural preparations
27. Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus-myoclonus
28. Anti-Hu antibody in a neuroblastoma-associated paraneoplastic syndrome
29. Antineuronal antibody in a patient with neuroblastoma and opsoclonus-myoclonus-ataxia: A case report
30. The neuropathology of paraneoplastic syndromes
31. Outcome of children with opsoclonus-myoclonus regardless of etiology
32. Neurological sequelae of the dancing eye syndrome
33. Treatment with intravenously administered immunoglobulins of the neuroblastoma-associated opsoclonus-myoclonus
34. Immune globulin G for treatment of opsoclonus-polymyoclonus syndrome
35. Opsoclonus. Pattern of regression in a child with neuroblastoma
36. Paraneoplastic syndrome in childhood
37. Single dose immunoglobulin therapy for childhood Guillain-Barre syndrome
38. Intravenous immunoglobulins in the therapy of paraneoplastic neurological disorders
39. Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies
40. Immunoglobulins in acute, parainfectious, disseminated encephalo-myelitis
41. Intravenous immune globulin therapy for neurologic diseases
42. Intravenous immunoglobulin treatment of neurological autoimmune diseases
43. Multifocal motor neuropathy improved by IVIg. Randomized, double-blind, placebo-controlled study
44. Neuroblastoma-associated opsoclonus-myoclonus treated with intravenously administered immune globulin G
45. Treatment of opsoclonus-myoclonus with high-dose intravenous immunoglobulin
46. High-dose i.v. human immunoglobulin in a case with infantile opsoclonus polymyoclonia syndrome
47. Effect of steroid and high-dose immunoglobulin therapy on opsoclonus-myoclonus syndrome occurring in neuroblastoma
48. Neurobehavioral and psychosocial functioning of children with opsoclonus-myoclonus syndrome
49. The cerebellar cognitive affective syndrome